Medical / Pharmaceuticals
Releases published in the last 30 days. 
Page 1 of 2
- New Episode of Medtech POV Podcast: Nanowear CEO Venk Varadan Details Medtech Startup Journey, Regulatory Pathway, and Payment Hurdles Facing Industry
- 4/25/2024 11:08:27 AM
- The newest episode of Medtech POV with Scott Whitaker, out on all podcast streaming platforms, highlights Venk Varadan’s journey as a medtech entrepreneur.
- AMA responds to UnitedHealth confirmation of stolen data from Change Healthcare
- 4/25/2024 11:03:14 AM
- The American Medical Association (AMA) is deeply concerned about the April 22 announcement from UnitedHealth Group (UHG) indicating vast amounts of sensitive medical data might have been stolen from Change Healthcare’s system and in the hands of malicious ransomware groups.
- ACCIONA Energía signs renewable PPA with DaVita in Spain
- 4/24/2024 12:29:15 PM
- • 12-year contract: The supply will come from the Ayora I-II-III photovoltaic complex in Jarafuel (Valencia), currently under development ACCIONA Energía has signed a power purchase agreement (PPA) with DaVita, leading medical services provider specialized in dialysis and kidney care services, to supply it with 100% renewable electricity in Spain for 12 years.
- Johnson & Johnson to Participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC)
- 4/23/2024 2:18:20 PM
- Johnson & Johnson (NYSE: JNJ) will participate in the Bernstein’s 40th Annual Strategic Decisions Conference (SDC) on Wednesday, May 29th, at the New York Hilton Midtown, New York, NY.
- NIH researchers develop AI tool with potential to more precisely match cancer drugs to patients
- 4/20/2024 10:09:30 PM
- What In a proof-of-concept study, researchers at the National Institutes of Health (NIH) have developed an artificial intelligence (AI) tool that uses data from individual cells inside tumors to predict whether a person’s cancer will respond to a specific drug.
- Maxxcanna Launches Limited-Time 30% Off on 420 Sale on All Items
- 4/20/2024 10:03:36 PM
- Maxxcanna, a leading Canada-based weed brand renowned for its commitment to quality and innovation in creating premium CBD and THC products, has announced its exclusive 4/20 sale this year.
- Shorten the Blanking Period After Atrial Fibrillation Ablation, Experts Say
- 4/18/2024 7:41:21 AM
- New evidence-based research calls into question the conventional three-month blanking period immediately after atrial fibrillation (AF) ablation, when early occurrences of AF are thought not to predict long-term AF recurrence.
- BrandShield and the Pharmaceutical Security Institute Release Annual Report Showing More than 6,900 Fraudulent Drug Listings and 1,600 Rogue Pharmacies Removed
- 4/15/2024 12:11:24 PM
- BrandShield together with the Pharmaceutical Security Institute, today announced its second annual Pharma Crime report carried out from January 2023 to December 2023.
- $6.9 Billion Weight Loss Telehealth Market Grows, But Gets Crowded
- 4/15/2024 6:00:00 AM
- April 15, 2024 - Marketdata LLC, a leading market research firm tracking the weight loss market since 1989, has released a new report: “The Telehealth Weight Loss Market”.
- AdvaMed to CMS: “1,138 Days Without Breakthrough Coverage is Harming Seniors”
- 4/12/2024 11:48:52 AM
- AdvaMed, the Medtech Association, unveiled a timer on the organization’s website to track the number of days since the Centers for Medicare and Medicaid Services (CMS) ended the coverage pathway for FDA-approved breakthrough medical devices.
- Physicians struggle to keep practices afloat after Change cyberattack
- 4/12/2024 11:45:31 AM
- The American Medical Association (AMA) released informal survey findings (PDF) showing the ongoing, devastating impact of the Change Healthcare cyberattack, which threatens the viability of physician practices across the country, and, according to respondents, has serious implications for patient care.
- Tackling cancer at the nanoscale
- 4/11/2024 7:33:31 AM
- When Paula Hammond first arrived on MIT’s campus as a first-year student in the early 1980s, she wasn’t sure if she belonged. In fact, as she told an MIT audience yesterday, she felt like “an imposter.” However, that feeling didn’t last long, as Hammond began to find support among her fellow students and MIT’s faculty.
- Can artificial intelligence techniques help clinicians assess and treat patients with bone fractures?
- 4/11/2024 7:27:16 AM
- The study, which is published in the Journal of Orthopaedic Research, uncovered a significant association between the rates of hospital readmission after fracture surgery and the presence of underlying medical conditions.
- Gilboa Therapeutics Presents Pre-clinical Data at AACR Supporting SolidT Engineered T-Cell Platform Targeting Solid Tumors
- 4/9/2024 5:49:25 PM
- Gilboa Therapeutics, a preclinical stage biotechnology company, today announced the presentation of pre-clinical data at the annual meeting of the American Association for Cancer Research demonstrating that its novel T-cell therapy platform, SolidT, has the potential to reprogram T cells to detect and destroy solid tumor cells while leaving normal cells unharmed, and …
- ACD/Labs’ Educational Software for Drawing Chemical Structures Achieves New Milestone
- 4/9/2024 9:00:00 AM
- ACD/Labs, an informatics company that develops and commercializes software in support of digitalized R&D, today announced that ChemSketch Freeware has been downloaded by over 2.5 million users worldwide.
- Culmination Bio Partners with BillionToOne to Drive Diagnostic Solutions in Oncology
- 4/4/2024 11:59:29 AM
- Culmination Bio, a data and technology company combining clinical and biospecimen data, announced a partnership with BillionToOne, Inc., a next-generation molecular diagnostics company with a mission to create powerful and accurate tests that are accessible to all.
- Risant Health completes acquisition of Geisinger
- 4/3/2024 11:37:26 AM
- Risant Health has announced the completion of its acquisition of Geisinger as its first health system dedicated to increasing access to value-based care and coverage.
- Influenza Health Worker Vaccination Programmes: Platforms for Pandemic Preparedness
- 3/30/2024 11:14:06 AM
- WHO recommends that HWs be vaccinated against a number of antigens (). Globally, countries have most frequently reported vaccinating HWs against hepatitis B, seasonal influenza and measles ( [ii] ).
- FDA Warns Consumers to Avoid Certain Topical Pain Relief Products Due to Potential for Dangerous Health Effects
- 3/28/2024 7:29:57 AM
- The U.S. Food and Drug Administration is warning consumers not to use certain over-the-counter analgesic (pain relief) products that are marketed for topical use to relieve pain before, during or after certain cosmetic procedures, such as microdermabrasion, laser hair removal, tattooing and piercing.
- Infection Control Testing Resources to Help Prevent the Spread of Klebsiella in Healthcare Settings
- 3/27/2024 8:57:55 AM
- Klebsiella is a type of gram-negative bacteria that can cause different types of serious healthcare-associated infections (HAIs). These can include pneumonia, bloodstream infections, wound or surgical site infections, and meningitis.